QSAR and k-Nearest Neighbor Classification Analysis of Selective Cyclooxygenase-2 Inhibitors Using Topologically-Based Numerical Descriptors

Experimental IC(50) data for 314 selective cyclooxygenase-2 (COX-2) inhibitors are used to develop quantitation and classification models as a potential screening mechanism for larger libraries of target compounds. Experimental log(IC(50)) values ranged from 0.23 to > or = 5.00. Numerical descriptors encoding solely topological information are calculated for all structures and are used as inputs for linear regression, computational neural network, and classification analysis routines. Evolutionary optimization algorithms are then used to search the descriptor space for information-rich subsets which minimize the rms error of a diverse training set of compounds. An eight-descriptor model was identified as a robust predictor of experimental log(IC(50)) values, producing a root-mean-square error of 0.625 log units for an external prediction set of inhibitors which took no part in model development. A k-nearest neighbor classification study of the data set discriminating between active and inactive members produced a nine-descriptor model able to accurately classify 83.3% of the prediction set compounds correctly.

[1]  R. Fletcher,et al.  A New Approach to Variable Metric Algorithms , 1970, Comput. J..

[2]  C. G. Broyden The Convergence of a Class of Double-rank Minimization Algorithms 2. The New Algorithm , 1970 .

[3]  D. Shanno Conditioning of Quasi-Newton Methods for Function Minimization , 1970 .

[4]  D. Goldfarb A family of variable-metric methods derived by variational means , 1970 .

[5]  Milan Randic,et al.  Search for all self-avoiding paths graphs for molecular graphs , 1979, Comput. Chem..

[6]  L. Kier Distinguishing Atom Differences in a Molecular Graph Shape Index , 1986 .

[7]  L. Kier Shape Indexes of Orders One and Three from Molecular Graphs , 1986 .

[8]  D. Manallack,et al.  Statistics using neural networks: chance effects. , 1993, Journal of medicinal chemistry.

[9]  Jon W. Ball,et al.  Quantitative structure‐activity relationships for toxicity of phenols using regression analysis and computational neural networks , 1994 .

[10]  Matthew D. Wessel,et al.  Prediction of Reduced Ion Mobility Constants from Structural Information Using Multiple Linear Regression Analysis and Computational Neural Networks , 1994 .

[11]  Brian T. Luke,et al.  Evolutionary Programming Applied to the Development of Quantitative Structure-Activity Relationships and Quantitative Structure-Property Relationships , 1994, J. Chem. Inf. Comput. Sci..

[12]  Peter C. Jurs,et al.  Automated Descriptor Selection for Quantitative Structure-Activity Relationships Using Generalized Simulated Annealing , 1995, J. Chem. Inf. Comput. Sci..

[13]  J. Gierse,et al.  Expression and selective inhibition of the constitutive and inducible forms of human cyclo-oxygenase. , 1995, The Biochemical journal.

[14]  C. Koboldt,et al.  1,2‐Diarylcyclopentenes as Selective Cyclooxygenase‐2 Inhibitors and Orally Active anti‐Inflammatory Agents. , 1996 .

[15]  P. Isakson,et al.  The discovery and function of COX-2. , 1997, The Journal of rheumatology. Supplement.

[16]  R. Kumar,et al.  Diarylspiro[2.4]heptenes (I) as Selective Cyclooxygenase-2 Inhibitors: A Quantitative Structure—Activity Relationship Analysis. , 1998 .

[17]  R. S. Rogers,et al.  Synthesis and biological evaluation of the 1,5-diarylpyrazole class of cyclooxygenase-2 inhibitors: identification of 4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benze nesulfonamide (SC-58635, celecoxib). , 1997, Journal of medicinal chemistry.

[18]  C. Koboldt,et al.  1,2-Diarylimidazoles as potent, cyclooxygenase-2 selective, and orally active antiinflammatory agents. , 1997, Journal of medicinal chemistry.

[19]  Lemont B. Kier,et al.  The E-State as an Extended Free Valence , 1997, J. Chem. Inf. Comput. Sci..

[20]  C. Koboldt,et al.  1,2‐Diarylpyrroles as Potent and Selective Inhibitors of Cyclooxygenase‐2. , 1997 .

[21]  D. Heijde The continuing challenge of predictive factors in rheumatoid arthritis: prediction or association? , 1997 .

[22]  R. Kumar,et al.  Novel inhibitors of cyclooxygenase-2: the sulfones and sulfonamides of 1,2-diaryl-4,5-difluorobenzene. Analysis of quantitative structure-activity relationship. , 1998, Journal of enzyme inhibition.

[23]  Zhiliang Li,et al.  Approach to Estimation and Prediction for Normal Boiling Point (NBP) of Alkanes Based on a Novel Molecular Distance-Edge (MDE) Vector , 1998, J. Chem. Inf. Comput. Sci..

[24]  Peter C. Jurs,et al.  Prediction of Human Intestinal Absorption of Drug Compounds from Molecular Structure , 1998, J. Chem. Inf. Comput. Sci..

[25]  C. Venturini,et al.  Non-steroidal anti-inflammatory drug-induced renal failure: a brief review of the role of cyclo-oxygenase isoforms. , 1998, Current opinion in nephrology and hypertension.

[26]  Steven L. Dixon,et al.  Investigation of classification methods for the prediction of activity in diverse chemical libraries , 1999, J. Comput. Aided Mol. Des..

[27]  R. Kumar,et al.  1,2-Diarylimidazoles as inhibitors of cyclooxygenase-2: a quantitative structure-activity relationship study. , 1999, Journal of enzyme inhibition.

[28]  J. Gálvez,et al.  Molecular search of new active drugs against Toxoplasma gondii. , 1999, SAR and QSAR in environmental research.

[29]  P. Jurs,et al.  Prediction of fathead minnow acute toxicity of organic compounds from molecular structure. , 1999, Chemical research in toxicology.

[30]  D. Gilroy,et al.  Inducible cyclooxygenase may have anti-inflammatory properties , 1999, Nature Medicine.

[31]  V. Zoete,et al.  Molecular orbital theory applied to the study of nonsteroidal anti-inflammatory drug efficiency. , 1999, Free radical biology & medicine.

[32]  D. E. Nichols,et al.  Quantitative structure-activity relationship modeling of dopamine D(1) antagonists using comparative molecular field analysis, genetic algorithms-partial least-squares, and K nearest neighbor methods. , 1999, Journal of medicinal chemistry.

[33]  M. Percival,et al.  The discovery of rofecoxib, [MK 966, Vioxx, 4-(4'-methylsulfonylphenyl)-3-phenyl-2(5H)-furanone], an orally active cyclooxygenase-2-inhibitor. , 1999, Bioorganic & medicinal chemistry letters.

[34]  A. K. Madan,et al.  Superpendentic Index: A Novel Topological Descriptor for Predicting Biological Activity , 1999, J. Chem. Inf. Comput. Sci..

[35]  J. Jaén-Oltra,et al.  Artificial neural network applied to prediction of fluorquinolone antibacterial activity by topological methods. , 2000, Journal of medicinal chemistry.

[36]  Kenneth K Wang,et al.  The "aspirin" of the new millennium: cyclooxygenase-2 inhibitors. , 2000, Mayo Clinic proceedings.

[37]  D. Lesieur,et al.  Comparative Molecular Field Analysis of Selective Cyclooxygenase‐2 (COX‐2) Inhibitors , 2000 .

[38]  C. Koboldt,et al.  Selective cyclooxygenase-2 inhibitors: heteroaryl modified 1,2-diarylimidazoles are potent, orally active antiinflammatory agents. , 2000, Journal of medicinal chemistry.

[39]  D. Hadjipavlou-Litina Quantitative structure--activity relationship (QSAR) studies on non steroidal anti-inflammatory drugs (NSAIDs). , 2000, Current medicinal chemistry.

[40]  P. Jurs,et al.  Classification of multidrug-resistance reversal agents using structure-based descriptors and linear discriminant analysis. , 2000, Journal of medicinal chemistry.

[41]  Peter C. Jurs,et al.  Prediction of IC50 Values for ACAT Inhibitors from Molecular Structure , 2000, J. Chem. Inf. Comput. Sci..

[42]  D. M. van der Heijde,et al.  Rofecoxib, a New Cyclooxygenase 2 Inhibitor, Shows Sustained Efficacy, Comparable With Other Nonsteroidal Anti-inflammatory Drugs A 6-Week and a 1-Year Trial in Patients With Osteoarthritis , 2000 .

[43]  P. McGettigan,et al.  Current problems with non-specific COX inhibitors. , 2000, Current pharmaceutical design.

[44]  G. Desiraju,et al.  Three-Dimensional Quantitative Structural Activity Relationship (3D-QSAR) Studies of Some 1,5-Diarylpyrazoles: Analogue Based Design of Selective Cyclooxygenase-2 Inhibitors , 2000 .

[45]  P. Jurs,et al.  Prediction of IC50 Values for ACAT Inhibitors from Molecular Structure. , 2000 .

[46]  G. Desiraju,et al.  Three-Dimensional Quantitative Structural Activity Relationship ( 3 D-QSAR ) Studies of Some 1 , 5-Diarylpyrazoles : Analogue Based Design of Selective Cyclooxygenase-2 Inhibitors , 2000 .

[47]  K. Giercksky,et al.  Selective inhibitors of COX-2--are they safe for the stomach? , 2000, Scandinavian journal of gastroenterology.

[48]  Gregory W. Kauffman,et al.  Prediction of Inhibition of the Sodium Ion—Proton Antiporter by Benzoylguanidine Derivatives from Molecular Structure. , 2000 .

[49]  F. Berenbaum Selective cyclooxygenase-2 inhibitors: hope and facts. , 2000, Joint, bone, spine : revue du rhumatisme.

[50]  J. Gálvez Use of molecular topology in the selection of new cytostatic drugs , 2000 .